ISIS-FXI

Bayer fronting $155M for a promising anticoagulant from Isis Pharma
Fierce Biotech
Mon, 05/4/15 - 10:08 am
Bayer
anticoagulants
Isis Pharmaceuticals
ISIS-FXI
antisense